Lanham O'Dell & Company, Inc. CPRX — CATALYST PHARMACEUTICALS INC

Ownership history in Lanham O'Dell & Company, Inc.  ·  15 quarters on record

AI Ownership Summary

Lanham O'Dell & Company, Inc. reported CATALYST PHARMACEUTICALS INC (CPRX) in 15 quarterly 13F filings from 2024 Q1 through 2025 Q4. Peak portfolio weight reached 0.21% in 2025 Q1. The latest visible filing shows CPRX at 0.08% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this CPRX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Lanham O'Dell & Company, Inc.'s position in CATALYST PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

CPRX was reported at 0.08% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.21% in 2025 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CPRX stock page Lanham O'Dell & Company, Inc. fund profile Lanham O'Dell & Company, Inc. full holdings
How Lanham O'Dell & Company, Inc. held CPRX — position size vs. price
% of Fund (quarterly)    CPRX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED — — — 12,000 -2,000 -14.3% 0.08% $280K 2026-02-14 (Est.) —
2025 Q3 UNCHANGED — — — 14,000 — 0% 0.09% $276K 2025-10-30 —
2025 Q2 REDUCED — — — 14,000 -1,000 -6.7% 0.13% $304K 2025-08-11 —
2025 Q1 UNCHANGED — — — 15,000 — 0% 0.21% $364K 2025-05-15 —
2024 Q4 REDUCED — — — 15,000 -2,000 -11.8% 0.17% $313K 2025-02-06 —
2024 Q3 REDUCED — — — 17,000 -3,000 -15.0% 0.19% $338K 2024-10-22 —
2024 Q2 UNCHANGED — — — 20,000 — 0% 0.17% $310K 2024-08-15 —
2024 Q1 REDUCED — — — 20,000 -645 -3.1% 0.16% $319K 2024-05-15 —
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding CPRX

As of 2026 Q2 — sorted by position size

Versor Investments LP 3Y 7Y 5.04% GABLES CAPITAL MANAGEMENT INC. 3Y 7Y 4.76% JW Asset Management, LLC 3Y 7Y 3.82% NEXPOINT ASSET MANAGEMENT, L.P. 3Y 3.37% GLAZER CAPITAL, LLC 3Y 7Y 2.79% WATER ISLAND CAPITAL LLC 3Y 7Y 2.73% Chicago Capital Management, LLC 3Y 7Y 2.61% HARVEST MANAGEMENT LLC 3Y 7Y 1.85% Athos Capital Ltd 3Y 7Y 1.67% Kintayl Capital LP 1.43%

FAQ About Lanham O'Dell & Company, Inc. and CPRX

These are the practical questions this page is built to answer before you even open the full history table.

How long has Lanham O'Dell & Company, Inc. reported owning CPRX?

Lanham O'Dell & Company, Inc. reported CPRX across 8 quarterly 13F filings, from 2024 Q1 through 2025 Q4.

What was the largest reported CPRX position in Lanham O'Dell & Company, Inc.'s portfolio?

The largest reported portfolio weight for CPRX was 0.21% in 2025 Q1.

What is the latest reported CPRX position on this page?

The most recent filing on this page is 2025 Q4, when Lanham O'Dell & Company, Inc. reported 12,000 shares, equal to 0.08% of portfolio, with an estimated market value of $280K.

What does the chart on this CPRX ownership page compare?

The chart compares Lanham O'Dell & Company, Inc.'s quarterly CPRX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Lanham O'Dell & Company, Inc. Holdings